BH3-mimetics in rational combination therapies to overcome treatment-resistant cancers

  • Roberts, Andrew (Primary Chief Investigator (PCI))
  • Wei, Andrew (Chief Investigator (CI))
  • Tam, Constantine S (Chief Investigator (CI))
  • Lindeman, Geoffrey J. (Chief Investigator (CI))
  • Huang, David C S (Chief Investigator (CI))
  • Herold, Marco J (Chief Investigator (CI))
  • Seymour, John (Chief Investigator (CI))
  • Mason, Kylie (Chief Investigator (CI))
  • Guthridge, Mark Andrew, (Chief Investigator (CI))

Project: Research

StatusActive
Effective start/end date22/05/1422/11/19

Funding

  • Victorian Cancer Agency: AUD2,480,792.00